Both Januvia and Semaglutide offer similar effectiveness in symptom control, with the main difference being how quickly they act. Either drug is a viable option depending on the patient’s needs.

Semaglutide is gentler on the liver and kidneys and has a better safety profile for long-term use, particularly for older patients or those with pre-existing conditions.

Both Januvia and Semaglutide have a low risk of addiction when used correctly under medical supervision, with minimal potential for misuse.

Januvia offers the convenience of a once-daily dose, simplifying treatment adherence for patients.

Both Januvia and Semaglutide have some contraindications based on individual health conditions, but neither has significantly more restrictions than the other.

Both drugs offer advantages depending on treatment goals. Januvia is great for fast relief, while Semaglutide is better for long-term management. The choice depends on the patient’s specific needs.